Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Gray Market Peptides: So Much Hype, So Little Data The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy